Filip Scheperjans

6.3k total citations · 3 hit papers
57 papers, 4.2k citations indexed

About

Filip Scheperjans is a scholar working on Neurology, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Filip Scheperjans has authored 57 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 15 papers in Molecular Biology and 12 papers in Cognitive Neuroscience. Recurrent topics in Filip Scheperjans's work include Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (16 papers) and Gut microbiota and health (14 papers). Filip Scheperjans is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (29 papers), Neurological disorders and treatments (16 papers) and Gut microbiota and health (14 papers). Filip Scheperjans collaborates with scholars based in Finland, Germany and United States. Filip Scheperjans's co-authors include Pedro A. B. Pereira, Velma T. E. Aho, Petri Auvinen, Eero Pekkonen, Lars Paulín, Karl Zilles, Simon B. Eickhoff, Katrin Amunts, Seppo Kaakkola and Johanna Eerola‐Rautio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Filip Scheperjans

53 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota are related to Parkinson's disease and clinical phenotype

2014 1.4k citations Filip Scheperjans, Velma T. E. Aho et al. profile →
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease

2021 312 citations Velma T. E. Aho, Pedro A. B. Pereira et al. profile →
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

2019 259 citations Velma T. E. Aho, Pedro A. B. Pereira et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Filip Scheperjans Finland	25	1.7k	1.5k	994	795	539	57	4.2k
Eero Pekkonen Finland	39	1.3k 0.8×	1.5k 1.0×	2.9k 3.0×	668 0.8×	406 0.8×	125	5.7k
Pascal Derkinderen France	47	1.9k 1.1×	3.2k 2.1×	349 0.4×	1.4k 1.7×	239 0.4×	142	7.0k
Collin Challis United States	11	2.2k 1.3×	1.2k 0.8×	240 0.2×	1.2k 1.5×	680 1.3×	16	4.4k
Marjatta Pohja Finland	8	878 0.5×	646 0.4×	383 0.4×	398 0.5×	302 0.6×	10	1.9k
Silke Appel‐Cresswell Canada	18	638 0.4×	1.9k 1.2×	332 0.3×	537 0.7×	147 0.3×	46	2.8k
Gauri G. Shastri United States	8	3.5k 2.0×	967 0.6×	159 0.2×	1.7k 2.2×	1.3k 2.3×	10	5.6k
Robin M. Voigt United States	30	2.4k 1.4×	1.3k 0.9×	136 0.1×	1.7k 2.1×	658 1.2×	85	5.3k
Harald Engler Germany	48	760 0.4×	171 0.1×	952 1.0×	885 1.1×	2.0k 3.7×	146	6.2k
Derrick F. MacFabe Canada	32	2.2k 1.3×	250 0.2×	1.6k 1.6×	682 0.9×	489 0.9×	44	4.3k
Ori Staszewski Germany	26	3.0k 1.8×	447 0.3×	142 0.1×	1.6k 2.0×	1.4k 2.5×	59	7.3k

Countries citing papers authored by Filip Scheperjans

Since Specialization

Citations

This map shows the geographic impact of Filip Scheperjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filip Scheperjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filip Scheperjans more than expected).

Fields of papers citing papers by Filip Scheperjans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filip Scheperjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filip Scheperjans. The network helps show where Filip Scheperjans may publish in the future.

Co-authorship network of co-authors of Filip Scheperjans

This figure shows the co-authorship network connecting the top 25 collaborators of Filip Scheperjans. A scholar is included among the top collaborators of Filip Scheperjans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filip Scheperjans. Filip Scheperjans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heinzel, Sebastian, Veera Kainulainen, Anni I. Nieminen, et al.. (2024). Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Scientific Reports. 14(1). 13513–13513. 10 indexed citations

Kuusela, A. L., Tuomas Mertsalmi, Tommi Noponen, et al.. (2024). Striatal Dopaminergic Function and Motor Slowing in Essential Tremor Plus. Movement Disorders Clinical Practice. 12(4). 464–474. 1 indexed citations

Shishido, Tânia Keiko, Pia Laine, Lars Paulín, et al.. (2024). Metagenome-assembled microbial genomes from Parkinson’s disease fecal samples. Scientific Reports. 14(1). 18906–18906. 3 indexed citations

Mertsalmi, Tuomas, et al.. (2023). Floating door sign does not differentiate Parkinson’s disease from essential tremor. Clinical Parkinsonism & Related Disorders. 8. 100184–100184.

Joutsa, Juho, Tuomas Mertsalmi, Eero Pekkonen, et al.. (2023). Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease. Brain and Behavior. 13(7). e3097–e3097. 4 indexed citations

Ronkainen, Aki, et al.. (2023). Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction. Microorganisms. 11(12). 2901–2901. 3 indexed citations

Cereda, Emanuele, Marco Severgnini, Michela Barichella, et al.. (2023). Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis. European Journal of Neurology. 30(11). 3581–3594. 42 indexed citations

Sinkkonen, Janne, Valtteri Kaasinen, Eero Pekkonen, et al.. (2023). Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s disease. SHILAP Revista de lepidopterología. 2(4). e0000225–e0000225. 4 indexed citations

Joutsa, Juho, Tero Vahlberg, Tommi Noponen, et al.. (2022). Diagnostic value of micrographia in Parkinson’s disease: a study with [123I]FP-CIT SPECT. Journal of Neural Transmission. 129(7). 895–904. 7 indexed citations

10.

Kessel, Sebastiaan P. van, Petri Auvinen, Filip Scheperjans, & Sahar El Aidy. (2021). Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease. npj Parkinson s Disease. 7(1). 115–115. 23 indexed citations

11.

Joutsa, Juho, et al.. (2021). Diagnostic accuracy of glabellar tap sign for Parkinson’s disease. Journal of Neural Transmission. 128(11). 1655–1661. 5 indexed citations

12.

Boertien, Jeffrey M., Pedro A. B. Pereira, Velma T. E. Aho, & Filip Scheperjans. (2019). Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review. Journal of Parkinson s Disease. 9(s2). S297–S312. 127 indexed citations

13.

Ortiz, Rebekka M., Filip Scheperjans, Tuomas Mertsalmi, & Eero Pekkonen. (2019). Comorbidity and retirement in cervical dystonia. Journal of Neurology. 266(9). 2216–2223. 18 indexed citations

14.

Joutsa, Juho, Tommi Noponen, Miia Pitkonen, et al.. (2019). Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [123I]FP-CIT SPECT. Journal of the Neurological Sciences. 404. 124–127. 4 indexed citations

15.

Scheperjans, Filip, Pascal Derkinderen, & Per Borghammer. (2018). The Gut and Parkinson’s Disease: Hype or Hope?. Journal of Parkinson s Disease. 8(s1). S31–S39. 64 indexed citations

16.

Pereira, Pedro A. B., Velma T. E. Aho, Lars Paulín, et al.. (2017). Oral and nasal microbiota in Parkinson's disease. Parkinsonism & Related Disorders. 38. 61–67. 152 indexed citations

17.

Scheperjans, Filip, Eero Pekkonen, Seppo Kaakkola, & Petri Auvinen. (2015). Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?. Journal of Parkinson s Disease. 5(2). 255–262. 65 indexed citations

18.

Scheperjans, Filip, Hartmut Mohlberg, Katrin Amunts, & Karl Zilles. (2005). Observer-independent cytoarchitectonic mapping of human superior parietal lobule and anterior medial intraparietal sulcus. JuSER (Forschungszentrum Jülich). 1 indexed citations

19.

Scheperjans, Filip, Christian Grefkes, Nicola Palomero‐Gallagher, Axel Schleicher, & Karl Zilles. (2005). Subdivisions of human parietal area 5 revealed by quantitative receptor autoradiography: a parietal region between motor, somatosensory, and cingulate cortical areas. NeuroImage. 25(3). 975–992. 63 indexed citations

20.

Scheperjans, Filip, Nicola Palomero‐Gallagher, Christian Grefkes, Axel Schleicher, & Karl Zilles. (2005). Transmitter receptors reveal segregation of cortical areas in the human superior parietal cortex: Relations to visual and somatosensory regions. NeuroImage. 28(2). 362–379. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact